BPC-157

Healing & Recovery Peptideresearch

Also known as: Body Protection Compound-157, Bepecin, PL 14736, PL-10

A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.

Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, originally isolated from human gastric juice. It is one of the most widely researched healing peptides in the biohacking and regenerative medicine communities. BPC-157 has demonstrated remarkable tissue-protective and regenerative properties across a wide range of animal studies, affecting tendons, ligaments, muscles, the gastrointestinal tract, the nervous system, and the vascular system. Its mechanism involves upregulation of growth factor expression, promotion of angiogenesis (new blood vessel formation), modulation of the nitric oxide system, and interaction with the dopaminergic system. While human clinical trials remain limited, the extensive preclinical evidence and widespread anecdotal use have made BPC-157 one of the most popular peptides for injury recovery and gut health.

Mechanism of Action

BPC-157 works through multiple interconnected pathways: (1) Upregulates growth factor receptors including VEGF, EGF, and FGF to promote angiogenesis and tissue repair; (2) Modulates the nitric oxide (NO) system, promoting vasodilation and blood flow to injured areas; (3) Interacts with the dopaminergic, serotonergic, and GABAergic neurotransmitter systems, offering neuroprotective effects; (4) Promotes reticulin and collagen formation, accelerating tendon and ligament repair; (5) Counteracts the damaging effects of NSAIDs, alcohol, and other GI-toxic agents on the gut lining; (6) Activates the FAK-paxillin pathway involved in cell migration and wound healing; (7) Modulates inflammatory cytokines to reduce excessive inflammation while supporting productive healing responses.

Molecular Formula

C62H98N16O22

Molecular Weight

1419.53 g/mol

Sequence

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Dosage Protocols

Dose Range

250mcg500mcg

Frequency

Twice daily

Route

subcutaneous

Cycle Length

4-12 weeks

Inject as close to the injury site as possible for localized healing. Split into morning and evening doses.

Source: Community protocols and clinical guidance

Side Effects

EffectSeverity
Injection site rednessmild
Nauseamild
Dizzinessmild
Headachemild
Fatiguemild

Pros & Cons

Extremely well-studied in animal models with consistent healing effects across virtually every tissue type

Unique stability in gastric juice allows effective oral administration, unlike most peptides

Very favorable safety profile with minimal reported side effects even at high doses

Multi-system benefits spanning gut, musculoskeletal, cardiovascular, and neurological systems

Can be injected locally near injury site for targeted healing

Lacks human randomized controlled trials — most evidence is from animal studies

Not FDA-approved and regulatory status is uncertain in many jurisdictions

Quality varies significantly between suppliers; purity is a concern with research-grade peptides

Banned by WADA, making it unusable for competitive athletes

Theoretical concern about promoting growth in existing tumors due to angiogenic properties (not demonstrated)

Research Studies

Legal Status

Not FDA-approved. Available as a research chemical in many countries. Classified as a 'research peptide' in the US. Banned by WADA for competitive athletes. Subject to increasing regulatory scrutiny.

Related Peptides